Keywords: sumitomo, market, astrazeneca, hibitane, general, antiseptic, chlorhexidine
Sumitomo to market AstraZeneca's Hibitane
Article | 24 July 2000
Sumitomo is to market AstraZeneca's general antiseptic Hibitane(chlorhexidine gluconate/n-propanol) in Japan, according to a report in the Nihon ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
